Predicting rectal tumor response to neoadjuvant chemoradiotherapy using plasma levels of carcinoembryonic antigen (CEA): Results from a tertiary center in Iran

OBJECTIVES: Nonsurgical treatment of colorectal cancer, the third most prevalent cancer worldwide, through chemoradiotherapy (CRT) has been suggested to induce complete remission. Carcinoembryonic antigen (CEA) has been used as a candidate marker to predict treatment response. In this study, we aime...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmadi Amoli, Hadi, Zarei, Rojan, Tayefeh Norooz, Mohammad, Najjari, Khosrow, Zabihi Mahmoudabadi, Hossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taibah University 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513620/
https://www.ncbi.nlm.nih.gov/pubmed/36212584
http://dx.doi.org/10.1016/j.jtumed.2022.06.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513620/
https://www.ncbi.nlm.nih.gov/pubmed/36212584
http://dx.doi.org/10.1016/j.jtumed.2022.06.009

Ejemplares similares